Timeline of Key Regulatory and Legal Events: September 9, 2025 FDA Warning Letter: The FDA issued a warning letter to Hims & Hers Health on September 9, 2025, finding false or misleading claims on its website about compounded semaglutide and tirzepatide, including phrases such as Same active ingredient as Ozempic and Wegovy and Clinically proven ingredients, which imply the compounded products are the same as FDA-approved drugs when they are not
L-Carnitine is widely recognized for its ability to help your body turn stored fat into usable energy, which is why its such a popular supplement among people trying to shed a few pounds or break through a stubborn plateau
Introducing new metabolic, longevity and personal support at BBHealth+ Trending now
Efficacy and safety of an mRNA-based RSV PreF vaccine in older adults
Horm Res 2004;62 Suppl 3:515.PubMed 35
Glutathione Benefits: Reduces oxidative stress